Ad is loading...
RYMDX
Price
$144.16
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
RYVLX
Price
$572.76
Change
+$1.69 (+0.30%)
Updated
Nov 22 closing price
Ad is loading...

RYMDX vs RYVLX

Header iconRYMDX vs RYVLX Comparison
Open Charts RYMDX vs RYVLXBanner chart's image
Rydex Mid-Cap 1.5x Strategy H
Price$144.16
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Rydex NASDAQ-100® 2x Strategy A
Price$572.76
Change+$1.69 (+0.30%)
VolumeN/A
CapitalizationN/A
RYMDX vs RYVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYMDX vs. RYVLX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYMDX is a Buy and RYVLX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.46B vs. RYMDX (16.2M). RYMDX pays higher dividends than RYVLX: RYMDX (0.31) vs RYVLX (0.00). RYMDX was incepted earlier than RYVLX: RYMDX (23 years) vs RYVLX (20 years). RYVLX is a more actively managed with annual turnover of: 461.00 vs. RYMDX (44.00). RYMDX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 53.22 vs. RYMDX (39.07). RYVLX return over 5 years is better than : 212.88 vs. RYMDX (48.48).
RYMDXRYVLXRYMDX / RYVLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years20 years-
Gain YTD22.13739.61956%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets16.2M1.46B1%
Annual Yield % from dividends0.310.00-
Returns for 1 year39.0753.2273%
Returns for 3 years-7.2910.72-68%
Returns for 5 years48.48212.8823%
Returns for 10 years125.40655.5219%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PK14.680.48
+3.38%
Park Hotels & Resorts
VITL31.030.90
+2.99%
Vital Farms
PTC192.754.25
+2.25%
PTC
ZNTL3.180.05
+1.60%
Zentalis Pharmaceuticals
BOLT0.57N/A
-0.56%
Bolt Biotherapeutics